IGM BIOSCIENCES INC (IGMS) Stock Income Statement
USA - NASDAQ:IGMS - US4495851085 - Common Stock
1.27 USD
-0.03 (-2.31%)
1.28 USD
+0.01 (+0.79%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 145.05M | 2.68M | 2.13M | 1.07M | 0.00 | |||
| Operating Expenses | 133.79M | 197.00M | 266.00M | 229.03M | 165.32M | |||
| Research and Development | 94.98M | 155.19M | 215.52M | 179.29M | 127.03M | |||
| Selling, General, and Administrative Expenses | 39.49M | 42.00M | 50.00M | 49.74M | 38.30M | |||
| Operating Income | 10.21M | -195.00M | -263.00M | -227.96M | -165.32M | |||
| Interest Income/Expense | 8.50M | 12.79M | 17.74M | 7.04M | N/A | |||
| Other Income/Expense | N/A | 0.00 | -20.00K | -180.00K | 160.00K | |||
| Non Recurring Items | -72.21M | -14.00M | N/A | N/A | N/A | |||
| Income Before Taxes | -53.00M | -196.00M | -246.00M | -221.10M | -165.16M | |||
| Income Tax | N/A | 0.00 | 680.00K | N/A | N/A | |||
| Net Income | -53.00M | -196.00M | -246.00M | -221.10M | -165.16M | |||
| EBITDA | 17.58M | -185.89M | -254.72M | -221.88M | -160.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.89 | -3.21 | -4.73 | -5.32 | -4.93 | |||
| Non GAAP EPS | -0.55 | -3.24 | -4.81 | -5.37 | -4.93 | |||
| Statistics | ||||||||
| Profit Margin | -36.54% | -7316.16% | -11549.30% | -20663.55% | N/A | |||
| Operating Profit Margin | 7.04% | -7278.84% | -12347.42% | -21304.67% | N/A | |||
All data in USD